Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000077967 | SCV000109796 | likely pathogenic | not provided | 2014-09-04 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001390637 | SCV001592435 | pathogenic | Adrenoleukodystrophy | 2020-02-12 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has been observed in individuals affected with X-linked adrenoleukodystrophy (PMID: 30902905). ClinVar contains an entry for this variant (Variation ID: 92328). This variant is not present in population databases (ExAC no frequency). This sequence change replaces alanine with glutamic acid at codon 205 of the ABCD1 protein (p.Ala205Glu). The alanine residue is highly conserved and there is a moderate physicochemical difference between alanine and glutamic acid. |
Genome- |
RCV001390637 | SCV002045811 | pathogenic | Adrenoleukodystrophy | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000077967 | SCV003824443 | uncertain significance | not provided | 2021-12-06 | criteria provided, single submitter | clinical testing |